Home
BOLD

BOLD

Boundless Bio Inc.

as of 12-16-2025 11:17am EST

$1.13

$0.01

-0.88%

Stocks Nasdaq

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Chart Type:

Time Range:

Founded:	2018	Country:	United States
Employees:	N/A	City:	SAN DIEGO
Market Cap:	26.2M	IPO Year:	2024
Target Price:	$4.00	AVG Volume (30 days):	183.8K
Analyst Decision:	Buy	Number of Analysts:	4
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-2.76	EPS Growth:	N/A
52 Week Low/High:	$1.00 - $3.12	Next Earning Date:	11-05-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered BOLD Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold

Model Accuracy: 71.93%

71.93%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full BOLD Forecast & Prediction with Hourly Data

Compare BOLD vs Leading Stocks

See how BOLD stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free BOLD Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "BOLD Boundless Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.